Hims & Hers (HIMS) is down -8.6%, or -$5.07 to $54.08.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Top Analyst Keeps Sell Rating on HIMS Stock Despite Buzz Around Women’s Health Expansion
- Sell Rating Issued for Hims & Hers Health Due to Limited Market Potential and High-Risk Investment
- Hims & Hers Health: Balancing Growth Enthusiasm with Competitive Challenges
- Hims & Hers Health Stock (HIMS) Soared 16% Today, Technical Indicators Still Suggest “Buy”
- Mixed options sentiment in Hims and Hers Health with shares up 9.56%